Migraine device wins 2021 MedTech Breakthrough Award
Nerivio is the first smartphone-controlled wearable for the treatment of acute migraine.
Nerivio is the first smartphone-controlled wearable for the treatment of acute migraine.
Biomed tech developer Theranica is included in ‘Electro-Charged Therapeutics’ category recognizing companies creating a drug-free future.
From devices to pharmaceuticals, Israeli approaches offer hope to the millions of migraine sufferers worldwide.
Theranica’s Nerivio Migra patch delivers a small electrical jolt to mitigate headaches and other acute pains through ‘conditioned pain modulation.’
Portable, wearable device will offer over-the-counter alternative to pills or surgery, to be used as needed.